Not applicableActive Not RecruitingNCT03672331What this trial is testingMy Personalized Breast ScreeningWho this might be right forBreast Screening UNICANCER 53,142
Not applicableLooking for participantsNCT06382818What this trial is testingPersonalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity ProbabilityWho this might be right forBreast Cancer Institut du Cancer de Montpellier - Val d'Aurelle 854
Large-scale testing (Phase 3)Looking for participantsNCT03201861What this trial is testingAddition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk WomenWho this might be right forTubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast RenJi Hospital 762
Not applicableNot Yet RecruitingNCT06722469What this trial is testingControlled Trial to Increase Breast Cancer Screening UptakeWho this might be right forBreast Cancer PreventionBreast Cancer Risk Chinese University of Hong Kong 470
Not applicableStudy completedNCT00066586What this trial is testingExemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerWho this might be right forBreast Cancer NCIC Clinical Trials Group 98
Not applicableStudy completedNCT00043472What this trial is testingRemoval of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic RiskWho this might be right forBreast CancerOvarian Cancer National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Large-scale testing (Phase 3)UnknownNCT05673629What this trial is testingUtidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast CancerWho this might be right forBreast Cancer Beijing Biostar Pharmaceuticals Co., Ltd. 552
Not applicableStudy completedNCT00032201What this trial is testingCell Lines From High-Risk Breast TissueWho this might be right forHealthy National Cancer Institute (NCI) 43
Not applicableStudy completedNCT02178475What this trial is testingProspective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk ChemotherapyWho this might be right forChemotherapy-induced Febrile Neutropenia Amgen 943
Not applicableUnknownNCT03617341What this trial is testingBrain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer Yonsei University 200
Not applicableNot Yet RecruitingNCT05848856What this trial is testingThe RISC Registry--Risk Informed Screening RegistryWho this might be right forBreast Cancer RiskCardiovascular Disease RiskCardiometabolic Risk+1 more Precision Health Equity Initiative 10,000
Testing effectiveness (Phase 2)Ended earlyNCT04149522What this trial is testingEvaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast CancerWho this might be right forBreast CancerRadiotherapy; Adverse Effect, Dermatitis or EczemaRadiotherapy Side Effect+3 more Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 40
Not applicableLooking for participantsNCT07498829What this trial is testingPopulation Based Germline Testing for Early Detection and Prevention of CancerWho this might be right forBreast Cancer RiskOvarian Cancer RiskCancer Gene Mutation Queen Mary University of London 6,000
Not applicableLooking for participantsNCT07121972What this trial is testingMirai-MRI: Validation of AI Models for Breast Cancer RiskWho this might be right forCancer RiskBreast Cancer Risk University of California, San Francisco 400
Not applicableStudy completedNCT03180086What this trial is testingBreast Cancer Risk Assessment in Women Aged 40-49Who this might be right forBreast Cancer Beth Israel Deaconess Medical Center 338
Testing effectiveness (Phase 2)Looking for participantsNCT07017673What this trial is testingPhase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast CancerWho this might be right forTNBCTNBC - Triple-Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma Cedars-Sinai Medical Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT05332561What this trial is testingGenomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)Who this might be right forEarly-stage Breast Cancer German Cancer Research Center 240
Not applicableStudy completedNCT06005025What this trial is testingExamination of the Effect of Counselling and Follow-up After Breast Cancer Awareness EducationWho this might be right forBreast CancerNurseEducation+2 more Tarsus University 160
Not applicableStudy completedNCT03918668What this trial is testingStudy for the Knowledge of Risk Factors Associated With Breast Cancer in WomenWho this might be right forBreast Neoplasm FemaleNutrition Related CancerHabits, Diet+1 more Instituto de Investigación Hospital Universitario La Paz 66